abstract |
THE INVENTION CONCERNS COMPOUNDS OF FORMULA (I), IN WHICH R2, R3, R4, R5, R6, R7, X, AND L REPRESENT ONE OF THE VALUES DEFINED IN THE SPECIFICATION, AND ACCEPTABLE PHARMACEUTICALLY ASSOCIATED SALTS, WHICH ARE USED IN AS AGENTS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AND OTHER DISORDERS, INCLUDING, HYPERACTIVITY DISORDER WITH ATTENTION DEFICIT, NEUROPATHIC PAIN, URINARY INCONTINENCE, ANXIETY, DEPRESSION, SCHIZOPHRENIA AND FIBROMYALGIA. This invention is also directed to pharmaceutical compositions containing at least one compound of Formula (I). |